Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks
Quince Therapeutics Inc (NASDAQ:QNCX) stock is trading sharply lower Thursday after the biotech company followed up Wednesday's rally with a Form 8-K that underscores how precarious its situation is. Here’s what investors need to know amid this week’s volatility.
- Quince Therapeutics stock is showing notable weakness. Why are QNCX shares down?
QNCX Stock Tumbles After Strategic Review Euphoria
The filing expands on this week's announcement that Quince hired LifeSci Capital as exclusive financial advisor to explore strategic alternatives, including a potential reverse merger.
The new disclosure shows Quince ended 2025 with about $5.8 million in cash and cash equivalents, $11.9 million in short-term investments and $16.4 million outstanding on an unsecured loan from the European Investment Bank.
Management also confirmed that lead candidate eDSP failed to meet primary or secondary endpoints in the NEAT trial, leaving the company with "no meaningful operations" and no resources to advance programs.
Reverse Merger, Delisting And Bankruptcy Risks Pressure Shares
Quince said the only path to shareholder value is executing a reverse merger with a private company, but noted it has no agreements in place and may not secure a deal on attractive terms, or at all. To fund the process, the company may issue more equity or debt and could use proceeds to pay down obligations.
The 8-K highlights risks around potential Nasdaq delisting, acceleration of the EIB loan and the possibility of Chapter 7 or 11 bankruptcy proceedings, where common shareholders would likely recover little or nothing.
QNCX Shares Plunge Thursday
QNCX Price Action: Quince Therapeutics shares were down 52.07% at 29 cents at the time of publication on Thursday. The stock is approaching its 52-week low of 12 cents.
Image: Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Reportedly, the US urges Japan to "increase" defense spending; Tokyo considers a 3.5% GDP target, bond market and yen come under pressure first
Under pressure from the United States, Japan is considering setting a new medium-term defense spending target, planning to increase its defense expenditure to 3.5% of GDP to align with NATO and other U.S. allies.
The logic of "cheap yen financing" is changing! Funds are reallocating "carry trades" as Swiss franc and Swedish krona compete for the funding currency position
The appeal of yen financing has diminished, and carry traders have recently turned their attention to the franc and the krona. With the yen’s recent surge making it a less reliable investment option, currencies such as the Swedish krona and Swiss franc are becoming primary funding choices for carry trades.
Crypto Regulation Deal Collapses: 5 Altcoins to Watch Before Volatility Turns Into the Next Buying Opportunity
Crypto prices
More
